Recently, we showed that a poly (ADP-ribose) polymerase 1 (PARP-1) inhibitor was neuroprotective in the R6/2 mouse model of HD, where sparing of striatal neurons was associated with an increased level of pCREB (Cardinale et al., 2015). Here, PARP1 is linked to Huntington disease.